First Houston Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
First Houston Capital's PFE Position: Q2 2017 in Review
First Houston Capital increased its Pfizer (PFE) stake by 8.9% in Q2 2017, buying an estimated $46.5K and bringing the position to 18,023 shares worth $574K. The position accounts for 0.57% of the portfolio, ranked #51.
First Houston Capital first reported a position in PFE in Q4 2013 and has held it in 15 quarters since. The position peaked at $2.89M in Q4 2015. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.
- First Houston Capital held 18,023 shares of Pfizer worth $574K as of Q2 2017.
- First Houston Capital bought 1,475 Pfizer shares in Q2 2017, an estimated $46.5K.
- Pfizer made up 0.57% of First Houston Capital's portfolio in Q2 2017, its #51 holding.
- First Houston Capital first reported a position in Pfizer in Q4 2013 and has held it in 15 quarters since.
- First Houston Capital's Pfizer position peaked at $2.89M in Q4 2015.
- 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.
Based on First Houston Capital's 13F filing for Q2 2017, filed 7 Aug 2017.